Cytodyn Inc (CYDY)

[Allnewsisgoodnews]

Thanks, the article says this may only be a 10-15 million (rough estimate) market per year in US,so here's a naive? scenario:
1. The rolling BLA could be approved for only the sickest patients, limit the application scope and the FDA may caapitulate.
2. CYDY sells some of it's stockpile for revenues of 15 million per year and gets a marketing and sales team up and running.
3. SP goes up on news and could trade for 20x earnings or $300 million.
4. Stock price is above $1, maybe can be uplisted to Nasdaq.
5. RP and NP can spend the next couple of years selling the cancer metastasis angle.
These steps are all hard work and not easy money, if they have a BP or MP, SP that wants to buy the IP of CYDY for $300 million than go for it. IMDZ sold for about $300 million to Merck, that sounds in the ballpark.